MedPath

body fat composition analysis in Indians with recently diagnosed diabetes.

Not yet recruiting
Conditions
Type 2 diabetes mellitus with unspecified complications,
Registration Number
CTRI/2020/08/027439
Lead Sponsor
PGIMER
Brief Summary

There are numerous risk factors that predispose one to developing T2 DM, like family history of Diabetes, obesity, sedentary life style etc. Amongst all of them, our study tends to elaborate on the correlation between obesity and T2 DM. Till now, Anthropometric measures like WC, WHR and BMI are being used as surrogate measures of obesity. But it has been found that Asian Indians are predisposed to develop Diabetes even at a lower BMI. With this scenario, it seems worthwhile to delve into knowing the total body composition and body fat distribution, both quantitatively and qualitatively, so as to predict the predisposition to Type 2 DM, using methods like Bioelectrical Impedance and Whole Body DEXA which provide more accurate measurements of the same.

Along with this, we tend to measure the levels of various inflammatory biomarkers like adiponectin, chemerin and hsCRP, as Diabetes is considered as the state of low grade inflammation.

Thus, we tend to study the body composition (structural and biochemical) in Asian Indians with recently diagnosed type 2 Diabetes Mellitus, with an intent to corroborate our hypothesis that the thin lean Asian Indian phenotype is a myth and that the Asian Indians developing T2 DM are also obese fat, similar to the Caucasian phenotype.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
159
Inclusion Criteria
  • Patients who are willing to give informed consent to participate in the study.
  • Patients diagnosed with Type 2 Diabetes Mellitus within a period of 24 weeks, as per ADA Diagnostic Criteria of Type 2 Diabetes Mellitus.
Exclusion Criteria
  • Patients who are not willing to give consent to participate in the study or to undergo DEXA, Bioelectrical Impedance, or blood Investigatons.
  • Patients with duration of Type 2 Diabetes Mellitus more than 24 weeks.
  • Patients taking drug therapy like Insulin, SGLT 2 Inhibitors and Sulphonylureas.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
visceral fat mass(g), volume (cm3), area(cm2) via DEXA scanat baseline
Secondary Outcome Measures
NameTimeMethod
Visceral fat rating via Bioelectrical Impedance, values of Biomarkers (Adiponectin, Chemerin, hsCRP), Anthropometry (Waist Circumference, Hip Circumference, Waist to Hip ratio, BMI)at baseline

Trial Locations

Locations (1)

PGIMER, Chandigarh

🇮🇳

Chandigarh, CHANDIGARH, India

PGIMER, Chandigarh
🇮🇳Chandigarh, CHANDIGARH, India
Rohan Goel
Principal investigator
8851741753
dr.rohangoel@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.